Yang Pei-Ming

21PUBLICATIONS
19CO-AUTHORS
Molecular targetsPredictive and prognostic markersChemotherapyHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 13, 2026
Fedratinib induces non-classical G2/M arrest via mitotic-kinase inhibition and synergizes with mitomycin C to suppress pancreatic ductal adenocarcinoma.

|Nov 10, 2025
A machine learning framework using urinary biomarkers for pancreatic ductal adenocarcinoma prediction with post hoc validation via single-cell transcriptomics.

Dahlak D Solomon, Ching-Chung Ko, Hsin-Yi Chen

|Apr 07, 2025
Emerging Roles of ACTL6A as an Oncogenic Hub: Transcriptional Regulation and Beyond.

Kelvin K Tsai, Li-Hsin Cheng, Chung-Chi Hsu

|Mar 11, 2025
Hypoxia-induced MIR31HG expression promotes partial EMT and basal-like phenotype in pancreatic ductal adenocarcinoma based on data mining and experimental analyses.

Ching-Chung Ko, Pei-Ming Yang

|Mar 13, 2024
Scutellaria baicalensis Induces Cell Apoptosis and Elicits Mesenchymal-Epithelial Transition to Alleviate Metastatic Hepatocellular Carcinoma via Modulating HSP90β.

Tung-Ho Wu, Tung-Yi Lin, Pei-Ming Yang

|Jan 27, 2024
ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells.

Tze-Sian Chan, Li-Hsin Cheng, Chung-Chi Hsu

Pageof 4

Frequent Collaborators

4 joint publications

Tung-Yi Lin

3 joint publications

Tai-Long Pan

3 joint publications

Kelvin K Tsai

2 joint publications

Kuen-Haur Lee